Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

100 results about "Artificial cell" patented technology

An artificial cell or minimal cell is an engineered particle that mimics one or many functions of a biological cell. The term does not refer to a specific physical entity, but rather to the idea that certain functions or structures of biological cells can be replaced or supplemented with a synthetic entity. Often, artificial cells are biological or polymeric membranes which enclose biologically active materials. As such, nanoparticles, liposomes, polymersomes, microcapsules and a number of other particles have qualified as artificial cells. Micro-encapsulation allows for metabolism within the membrane, exchange of small molecules and prevention of passage of large substances across it. The main advantages of encapsulation include improved mimicry in the body, increased solubility of the cargo and decreased immune responses. Notably, artificial cells have been clinically successful in hemoperfusion.

Preparation technology of PCL/GE (polycaprolactone/gelatin) electrospinning composite stent

The invention discloses a preparation technology of a PCL / GE (polycaprolactone / gelatin) electrospinning composite stent, and belongs to the technical field of biological tissue engineering stents. The preparation technology sequentially comprises a preparation technology of a PCL / GE nanometer fiber electrospinning film which is made of an artificial cell extracellular matrix (ECM) stent material, a preparation method of an electrospinning film coated with hydroxyapatite crystals, and a building method of the electrospinning composite stent. The preparation technology has the advantages that the electrospinning film coated with the hydroxyapatite crystals and the PCL / GE electrospinning film are combined to form an ECM structure which is similar to natural bone tissues; the prepared electrospinning composite stent has no obvious cell toxicity, the internal stent structure is similar to the ECM of the natural bone tissues, and the outer layer structure can block the invasion of peripheral connective tissues; the biocompatibility is good, and the regeneration of bone tissues can be effectively promoted; a stable environment is provided for the regeneration of new bones, and the structure and function of the ECM of the normal bone tissues can be simulated.
Owner:JIANGSU PROVINCE HOSPITAL

Amphiphilic porous hollow carbon microsphere as well as preparation method and application thereof

The invention discloses an amphiphilic porous hollow carbon microsphere, a preparation method thereof, applications of the amphiphilic porous hollow carbon microsphere as a carrier in enriching and loading of active molecules or a catalyst, and a method for separating and recovering the porous hollow carbon microsphere from a dispersion system by utilizing the amphipathy. The method comprises thefollowing steps of: dispersing microzyme in an aqueous solution of a cytoderm surface protectant; and then, carrying out carbonation treatment to obtain the amphiphilic porous hollow carbon microsphere. The prepared hollow carbon microsphere has a pore size capable of being controlled in the mesoporous and macroporous range as required, and can be suitable for the loading, the storage and the transmission of guest molecules in different sizes; by utilizing the characteristic of the amphiphilic porous hollow carbon microsphere capable of spontaneously transferring to a two-phase interface froma polar or non-polar dispersion system, the microsphere can be conveniently separated and recovered from a reaction mixing system. The easy and low-cost synthesis method and the special properties ofthe hollow carbon microsphere are favorable to the applications of the hollow carbon microsphere to the fields, such as energy storage, medicament transmission, artificial cells, catalytic carriers, and the like.
Owner:CHINA AGRI UNIV

Artificial cell membrane materials applied to photoinduction stem grafting and synthesis method thereof

InactiveCN103483480ADoes not affect mechanical propertiesDoes not affect structural propertiesCoatingsPropanoic acidBiocompatibility Testing
The invention discloses artificial cell membrane materials applied to photoinduction stem grafting and a synthesis method of the artificial cell membrane materials. The synthesis method of the artificial cell membrane materials comprises the following steps that 2-(dodecyl trithiocarbonate)-2- methyl propionic acid, dicyclohexyl carbodiimide, 4- dimethylamino pyridine and dichloromethane are added into a flask, all the components are stirred and dissolved under the protection of nitrogen, azide ethanol is dropwise added and stirred, washing is carried out through diluted hydrochloric acid and distilled water, solvents are removed through a reduced pressure distillation method, and a yellow oily liquid a is obtained; MPC, a midbody a, azo different nitrile and absolute ethyl alcohol are added into a boiling tube and are evenly dissolved, then after the nitrogen is removed through three times of 'vacuumizing-induction of highly pure nitorgen' operations on the boiling tube, and reaction away from light is carried out on the boiling tube in a sealed mode under the protection of highly pure nitrogen; the reaction liquid is precipitated through trichloromethane/diethyl ether mixed solvents, and solid products are collected. By means of the technical scheme, the artificial cell membrane materials have good biocompatibility, achieve the various effects of restraining of protein adsorption, anticoagulation, surface lubrication and the like, and have good medical prospects.
Owner:西安维萃禾生物科技有限公司 +1

Controllable preparation method of liposome vesicle based on microfluidic device

The invention provides a preparation method of a liposome vesicle based on a microfluidic device. The preparation method comprises the steps of: preparing a microfluidic chip by a soft lithography method; preparing a precursor solution for preparing the liposome vesicle; and using a constant-pressure injection pump to inject the precursor solution into a ''Y''-shaped chip through different injection ports, setting a total flow rate, adjusting the flow ratio of a buffer solution to a phospholipid molecular alcohol solution, and collecting a product at an outlet, wherein the product is the prepared liposome vesicle. The microfluidic chip selected by the invention is a ''Y''-shaped microfluidic chip with a serpentine mixing channel of a square structure, and the chip is prepared by the soft lithography method. By using the chip, based on the principle of self-assembly on an interface, by adjusting the total flow rate and the flow rate ratio of the aqueous buffer solution to the phospholipid molecule ethanol solution, regulation of the size of the liposome vesicle and control on the dimensional uniformity are achieved, and an efficient low-cost method is provided for preparation of artificial cells with uniform properties as well as drug carriers.
Owner:SHANGHAI UNIV

Human endothelial cell cadherins fusion protein, and preparation method and application thereof

InactiveCN104804098APromotes rapid endothelializationImproved vascularization of tissue engineeringArtificial cell constructsVertebrate cellsProtein CGrowth cell
The invention aims to build an expression plasmid of a fusion protein hVE-cad-Fc of an extracellular structural domain segment of human blood vessel endothelium cadherins protein and an Fc segment of immunoglobulin G by utilizing a genetic engineering technology for the first time, and realize biosynthesis of hVE-cad-Fc fusion protein using eukaryotic cells. The fusion protein forms a stable hVE-cadhrin functional protein layer matrix on the material surface via Fc mediation, so that not only is the hydrophilia of hydrophobic materials improved, but also the property of the endothelial cell selective adhesion to the material surface is greatly improved; in addition, the expression of the endothelial cell proliferation and differentiation functions is improved. According to the invention, the isologous association of the hVE-cad-Fc fusion protein matrix and VE-cadherin positively expressed on the cell surface activates the intercellular adhesion link signal path, and through the synergistic effect with the blood vessel endothelium cell growth factors, the expression of the adhesion, proliferation, anti-apoptosis and differentiation functions of the blood vessel endothelium cells are regulated and controlled; the hVE-cad-Fc fusion protein provided by the invention can be used to improve the affinity of the material endothelium cells, promote the functional modification of artificial extracellular matrix subjected to tissue engineering vascularization / endothelialization and biomedical materials.
Owner:NANKAI UNIV

Preparation method of thylakoid-containing artificial cells and photosynthesis simulating method

The invention relates to a preparation method of thylakoid-containing artificial cells and a photosynthesis simulating method, and belongs to the fields of biotechnology, biochemistry and synthetic biology. The method comprises the following steps of extracting thylakoid particles from fresh spinach leaves, and storing the thylakoid particles in a buffer solution for use; smearing a phospholipid solution onto an ITO glass electrode; after the solvent volatilization, forming a layer of phospholipid membrane; fixing a polytetrafluoroethylene framework by vacuum grease; adding liquid phases intothe polytetrafluoroethylene framework; applying alternating current onto the ITO glass electrode for preparing a GUV solution; mixing the GUV solution and a thylakoid solution; preparing the thylakoid-containing artificial cells. The thylakoid-containing artificial cells are prepared through the enlightenment of the natural plant cell structure and function; the model can realize the optical driveelectron transfer process under the artificial sunlight irradiation. Through the model building, the attributes of chloroplasts in nature are doubly simulated from the structure and the function. Thecomplicated cells realize simplified research, so that the development and the progress of the biomimetic chemistry are promoted.
Owner:HARBIN INST OF TECH

Novel activating agent for immune cell amplification and preparation method thereof

The invention discloses a novel activating agent for immune cell amplification and a preparation method thereof. The novel activating agent is prepared from the following ingredients in parts by weight: 20 to 26 percent of biological conductive nanometer fiber, 1 to 3 percent of power generation cells, 3 to 4 percent of gel mixed solution, 9 to 11 percent of composite agonists, 12 to 14 percent ofartificial cell membranes, 0.3 to 0.8 percent of cell membrane activators, 8 to 10 percent of specific antibodies and the balance of culture base solution. A great part of biological conductive nanometer fiber is used for performing loading on the composite agonists; then, the artificial cell membranes are used for coating; finally, after the treatment and activation by cell membrane activating materials, a specific antibody is combined; the power generation cells and the gel mixed solution are planted on the other small part of biological conductive nanometer fiber; then, the two parts of biological conductive nanometer fiber are put into a culture base solution to form the novel activating agent for immune cell amplification. Generally, the novel activating agent can improve the in vitro proliferation rate of immune cells by 10 to 15 times.
Owner:大连金玛健康产业发展有限公司

Construction method of tissue engineered tissue based on artificial cell

ActiveCN103349795AImprove permeabilityReduce high porosityProsthesisPorosityBiology
The invention provides a construction method of a tissue engineered tissue based on an artificial cell. The method comprises the following steps of: floating a cell suspension in a filtered and sterilized sodium alginate solution, and dropping the cell suspension into a calcium chloride solution through a dropping liquid generation device to form a calcium alginate bead; placing the bead into a membrane material contained solution, and coating a membrane on the surface of the bead to form a microcapsule, wherein the bead is cleaned by using normal saline; then, neutralizing superfluous positive charges on the surface of the microcapsule; liquefying the calcium alginate bead in the microcapsule by using a sodium citrate solution to form the artificial cell; next, curing and forming a mixture of the artificial cell and an aquogel to finally form an artificial cell and aquogel complex; and placing the artificial cell and aquogel complex under a static or oscillatory or microgravity condition to culture to construct the tissue engineered tissue. By using the construction method, the requirement of the traditional support for high porosity and high connectivity rate can be reduced; and the construction method is simple and beneficial to the realization of large-scale production for in-vitro construction.
Owner:南通美韦德生命科学有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products